ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Annexon, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$4.01+0.60 (+17.60%)
Close on Oct 19, 2026
- Market cap
- $806.02M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Share price
+$0.86 (+27.30%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $806.02M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 4.33
- Dividend yield
- 0.00%
- Free cash flow yield
- -23.97%
Fundamentals
- Net income
- -$202.67M
- EPS, diluted
- -$1.16
- Free cash flow
- -$193.22M
- Book value per share
- $0.93
- Diluted shares
- 201M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Operating income
-$210.56M
Net income
-$202.67M
EPS, diluted
-$1.16
Free cash flow
-$193.22M
Reported periodTrailing twelve months